1.Gorman C, Park A & Dell K (2004) Health: the fires within. Time (23 February, USA edition) 163(8), 38–45.
2.Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
3.Bastard JP, Maachi M, Lagathu C et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17, 4–12.
4.Festa A, D'Agostino R Jr, Williams K et al. . (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407–1415.
5.Park HS, Park JY & Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69, 29–35.
6.Bulló M, García-Lorda P, Megias I et al. (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11, 525–531.
7.Hermsdorff HH, Zulet MA, Puchau B et al. (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34, 161–170.
8.Lapice E, Maione S, Patti L et al. (2009) Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care 32, 1734–1736.
9.Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21, 697–738.
10.Wärnberg J, Nova E, Romeo J et al. (2007) Lifestyle-related determinants of inflammation in adolescence. Br J Nutr 98, Suppl. 1, S116–S120.
11.Quijada Z, Paoli M, Zerpa Y et al. (2008) The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes 9, 464–471.
12.Weiss R, Dziura J, Burgert TS et al. (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350, 2362–2374.
13.Halle M, Korsten-Reck U, Wolfarth B et al. (2004) Low-grade systemic inflammation in overweight children: impact of physical fitness. Exerc Immunol Rev 10, 66–74.
14.Reinehr T, Stoffel-Wagner B, Roth CL et al. (2005) High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 54, 1155–1161.
15.Gupta A, Ten S & Anhalt H (2005) Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18, 75–82.
16.Aeberli I, Molinari L, Spinas G et al. (2006) Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr 84, 748–755.
17.Giordano P, Del Vecchio GC, Cecinati V et al. (2011) Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr 170, 845–850.
18.Gøbel RJ, Jensen SM, Frøkiaer H et al. (2012) Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paediatr 101(2), 192–200.
19.Wärnberg J, Nova E, Moreno LA et al. (2006) Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 84, 505–512.
20.Martínez-Gómez D, Eisenmann JC, Wärnberg JA et al. (2010) Associations of physical activity, fitness and fatness with low-grade inflammation in adolescents. The AFINOS study. Int J Obes (London) 34, 1501–1507.
21.Ruiz JR, Ortega FB, Warnberg J et al. (2007) Associations of low-grade inflammation with physical activity, fitness and fatness in prepubertal children; the European Youth Heart Study. Int J Obes (Lond) 31, 1545–1551.
22.Romeo J, Martínez-Gómez D, Díaz LE et al. (2011) Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment programme in overweight adolescents: preliminary findings from the EVASYON study. Pediatric Diabetes 12, 372–380.
23.Martí A, Marcos A & Martínez JA (2001) Obesity and immune function relationships. Obes Rev 2, 131–140.
24.Sheridan PA, Paich HA, Handy J et al. (2011) Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond), doi: 10.1038/ijo.2011.208. (Epublication ahead of print version).
25.Caspar-Bauguil S, Cousin B, Galinier A et al. (2005) Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 579, 3487–3492.
26.Saely CH, Geiger K & Drexel H (2010) Brown versus white adipose tissue: a mini-review. Gerontology 58(1), 15–23.
27.Poglio S, de Toni-Costes F, Arnaud E et al. (2010) Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 28, 2065–2072.
28.Weisberg SP, McCann D, Desai M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
29.Lumeng CN, Bodzin JL & Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
30.Odegaard JI, Ricardo-González RR, Goforth MH et al. (2007) Macrophage-specific PPAR-gamma controls alternative activation and improves insulin resistance. Nature 447, 1116–1120.
31.Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347–355.
32.Tilg H & Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature 6, 772–783.
33.Koerner A, Kratzsch J & Kiess W (2005) Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19, 525–546.
34.Virtue S & Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective. Biochim Biophys Acta 1801, 338–349.
35.Pietiläinen KH, Róg T, Seppänen-Laakso T et al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9, e1000623.
36.Stryjecki C & Mutch DM (2011) Fatty acid-gene interactions, adipokines and obesity. Eur J Clin Nutr 65, 285–297.
37.Suganami T, Tanimoto-Koyama K, Nishida J et al. (2007) Role of the toll-like receptor 4/NF-kappa B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27, 84–91.
38.Fernández-Real JM, Vendrell J & Ricart W (2005) Circulating adiponectin and plasma fatty acid profile. Clin Chem 51, 603–609.
39.Pérez de Heredia F, Sánchez J, Priego T et al. (2009) Adiponectin is associated with serum and adipose tissue fatty acid composition in rats. J Endocrinol Invest 32, 659–665.
40.Coll T, Barroso E, Álvarez-Guardia D et al. (2010) The role of peroxisome proliferator-activated receptor beta/delta on the inflammatory basis of metabolic disease. PPAR Res, pii, 368467.
41.Fessler MB, Rudel LL & Brown JM (2009) Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 20, 379–385.
42.Grunfeld C & Feingold KR (1991) The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3, 143–158.
43.Mei M, Zhao L, Li Q et al. (2011) Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis 10, 1–10 (Epublication ahead of print version).
44.Gregor MF & Hotamisligil GS (2007) Thematic review series: Adipocyte biology. adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905–1914.
45.Trayhurn P, Pérez de Heredia F, Wang B et al. (2010) Hypoxia – role in adipocyte function and dysfunction. In Novel Insight into Adipose Cell Functions, pp. 45–60 [Clément K, Spiegelman BM and Christen Y, editors]. Berlin, Heidelberg: Springer-Verlag.
46.Pérez de Heredia F, Wood IS & Trayhurn P (2010) Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, MCT4) expression in human adipocytes. Pflüg Arch – Eur J Physiol 459, 509–518.
47.Samuvel DJ, Sundararaj KP, Nareika A et al. (2009) Lactate boosts TLR4 signaling and NF-ΚB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol 182, 2476–2484.
48.Pérez de Heredia F, Wood IS & Trayhurn P (2010) Lactate enhances the inflammatory response in human preadipocytes in vitro. Obes Rev 11, Suppl. 1, 122 (Abstract).
49.Halberg N, Khan T, Trujillo ME et al. (2009) Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29, 4467–4483.
50.Cancello R, Tordjman J, Poitou C et al. (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554–1561.
51.Hernández-Morante JJ, Milagro F, Gabaldón JA et al. (2006) Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 155, 593–600.
52.Villaret A, Galitzky J, Decaunes P et al. (2010) Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59, 2755–2763.